GLSI: Greenwich LifeSciences, Inc. Stock

by  •  • Comments Off on GLSI: Greenwich LifeSciences, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 116.20
Enterprise Value ($M) 112.11
Book Value ($M) 2.53
Book Value / Share 0.19
Price / Book 45.86
NCAV ($M) 2.53
NCAV / Share 0.19
Price / NCAV 45.89

Profitability (mra)
Return on Invested Capital (ROIC) -6.23
Return on Assets (ROA) -2.87
Return on Equity (ROE) -3.08

Liquidity (mrq)
Quick Ratio 2.62
Current Ratio 2.62

Balance Sheet (mrq) ($M)
Current Assets 4.09
Assets 4.09
Liabilities 1.56
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -16.01
Net Income -15.79

Cash Flow Statement (mra) ($M)
Cash From Operations -7.27
Cash from Investing 0.00
Cash from Financing 4.37

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-04-15 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-05-20 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 29,637 67,510 43.90
2025-04-16 18,721 48,846 38.33
2025-04-15 64,749 165,604 39.10

(click for more detail)

Similar Companies
GDTC – CytoMed Therapeutics Limited GELS – Gelteq Limited
GLMD – Galmed Pharmaceuticals Ltd. GLTO – Galecto, Inc.
GLYC – GlycoMimetics, Inc.


Financial data and stock pages provided by
Fintel.io